We fight to change economic policy and narratives in order to build public power, break up concentrations of private power, and deliver true opportunity and prosperity for all.
Watch VideoTrump’s blatant corruption is putting American retirement savings at risk.
At its core, this hearing in front of the Senate Judiciary Committee concerns a simple, age-old principle: Americans deserve fair pricing.
Groundwork Collaborative and Ipsos recently conducted a survey of American workers to assess how AI is affecting America’s workforce and worker sentiment about AI.
School supplies and lunches will cost families nearly $4,000 this school year.
One year after the passage of the so-called One Big Beautiful Bill Act, New Yorkers are grappling with the consequences.
Trump's tariff policies have created a new corporate cash grab.
After decades of deregulation and complacency, the time is ripe to embark on a grand national project to fundamentally rethink how energy is generated and distributed in the U.S.
Many go-to summertime staples — including ground beef, popsicles, and potato salad — are up more than 20% in just one year, nearly five times the overall inflation rate.
One year after the passage of the so-called One Big Beautiful Bill Act (OBBBA), families across the country are still grappling with a cost of living crisis exacerbated by President Trump’s economic agenda.
Americans pay more for prescription drugs than patients in any other wealthy country, and it's not just due to exorbitant pricing by drug manufacturers. Three corporate middlemen — CVS Caremark, Express Scripts, and OptumRx — control key channels in the drug supply chain, including roughly 80% of prescription claims in the U.S. Their business model artificially inflates and benefits from high drug prices. Government regulation and enforcement is not enough.
